Dr. Amy D. Tiersten, MD

Dr. Tiersten practices at The Mount Sinai Hospital in New York, New York, part of Mount Sinai Health System.

Dr. Tiersten's NPI, 1558362566, was assigned on August 2, 2005. Dr. Tiersten graduated from New York University School of Medicine in 1990. Dr. Tiersten holds New York license 186341.

Dr. Tiersten's primary practice is The Mount Sinai Hospital, at One Gustave L Levy Place, New York, NY 10029 in New York County. The practice phone is (212) 241-7981. Dr. Tiersten also practices at The Mount Sinai Hospital, 1 Gustave L Levy Pl, New York, NY 10029.

Dr. Tiersten's primary practice is The Mount Sinai Hospital in New York, New York, part of Mount Sinai Health System. Dr. Tiersten is also affiliated with Mount Sinai West. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Dr. Tiersten to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tiersten practices, 5 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Tiersten's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Tiersten is board certified in medical oncology by the American Board of Internal Medicine. Dr. Tiersten is licensed in New York.

Dmand AI lists muscle pain, fibromyalgia, and limb pain, osteoporosis, pulmonary embolism, sepsis and vision problems among the conditions Dr. Tiersten treats.

CMS data shows 1,007 Medicare services from Dr. Tiersten across 4 procedure codes in 2024, for 346 Medicare patients. Medicare paid $64,998 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 346 Medicare patients who saw Dr. Tiersten in 2024. The largest group is 65 to 74, with 167 patients. 75% of them have cancer, and 74% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tiersten's median patient age at 62, with 95% women.

In 2024, Dr. Tiersten wrote 1,021 Medicare Part D claims for 293 patients. 94% of them were for generic drugs. CMS names the drug for 917 of them, across 16 drugs with 11 or more claims each, at $39,734 in total drug cost. In 2023, CMS named 1,116 claims across 15 drugs.

Dr. Tiersten accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 66 papers to Dr. Tiersten, published from 2009 to 2024. 2014 was the busiest year, with 6. The most frequent topics are Breast Neoplasms, Antineoplastic Combined Chemotherapy Protocols and Ovarian Neoplasms. Dr. Tiersten has published most often in Gynecol Oncol. Dr. Tiersten's most frequent co-authors are Brittney Shulman Zimmerman, MD, Dawn Lauryn Hershman, MD and Stephanie V. Blank, MD.

Dmand AI links Dr. Tiersten to 30 clinical trials, 15 of them phase 2 studies. 7 are still active or recruiting. Conditions studied include Breast Neoplasms, Breast Diseases and Carcinoma, Ovarian Epithelial. Icahn School of Medicine at Mount Sinai sponsors the most, 5. Open Payments lists research payments to Dr. Tiersten that name 2 trials.

CMS Open Payments shows 224 general payments to Dr. Tiersten from 20 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 54% of the total. Amgen Inc. paid the most, $64,907. It also lists 2 research payments totaling $20,167 from 2016 to 2018, naming 2 clinical trials.

Dmand AI lists 2 awards for Dr. Tiersten, most recently CMS Stage 1 EHR in 2012.

Dr. Tiersten graduated from New York University School of Medicine in 1990. Dr. Tiersten is a member of ASCO.

Dr. Tiersten is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.